Priorix

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2017
012319982017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
BACKGROUND In July 2006, Priorix-Tetra™, a combined measles-mumps-rubella-varicella (MMRV) vaccine, was licensed in Germany… (More)
Is this relevant?
2012
2012
60 children aged 1-2 years old (32 boys and 28 girls) were vaccinated with Priorix. Vaccinated children included healthy control… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2010
2010
Children aged 11 to <24 months received 2 intranasal doses of live attenuated influenza vaccine (LAIV) or placebo, 35+/-7 days… (More)
Is this relevant?
2009
2009
Measles, mumps, and rubella are three common viral childhood diseases that can have serious complications. Active immunization… (More)
Is this relevant?
2007
2007
Measles-mumps-rubella (MMR) vaccines containing the Urabe strain of mumps were withdrawn in the United Kingdom in 1992 following… (More)
  • table 2
Is this relevant?
2007
2007
BACKGROUND This open, randomized, controlled study [208136/018] assessed the safety and immunogenicity of early vaccination with… (More)
Is this relevant?
2006
2006
The aim of this study was to investigate whether, the vaccine Priorix causes less immediate injection pain than MMR-II in… (More)
Is this relevant?
2002
2002
The reactogenicity and immunogenicity of three combined measles, mumps and rubella (MMR) vaccines and one administered with a… (More)
Is this relevant?
2000
2000
A large single blind, multi-centre study involving 1779 children was performed in Italy. Infants, aged between 12 and 27 months… (More)
Is this relevant?
1998
1998
Concerns about the association of aseptic meningitis with measles-mumps-rubella (MMR) vaccines containing the Urabe Am 9 strain… (More)
Is this relevant?